The efficacy and safety of hepatic arterial infusion chemotherapy based on folfiri for advanced intrahepatic cholangiocarcinoma as second-line and successive treatment: a real-world study

HIGHLIGHTS

• who: Peixin Huang et al. from the Department of Hepatic Oncology, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China have published the paper: The Efficacy and Safety of Hepatic Arterial Infusion Chemotherapy Based on FOLFIRI for Advanced Intrahepatic Cholangiocarcinoma as Second-Line and Successive Treatment: A Real-World Study, in the Journal: Canadian Journal of Gastroenterology and Hepatology of 26/09/2022
• what: The aim was the feasibility of treatment with secondary objectives of disease control rate (DCR) and 6-month survival rate. This study provides preliminary evidence that FOLFIRI-HAIC exhibits partial efficacy . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.